Gustav Gaudernack

Gustav Gaudernack was the professor and head of Unit for Immunotherapy at Radiumhospitalet from 1995 to 2011. He initiated over 20 clinical studies in cancer vaccination, including the first peptide vaccine study in cancer world wide (mutant RAS). Gustav Gaudernack has more than 50 patents and 15 licenses of monoclonal antibodies, cancer vaccines and cancer diagnostics. He has more than 200 peer-reviewed scientific articles.